← Eichor
Condition: Severe Pneumonia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Severe Pneumonia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Phase 1 · 2 location(s) · Shionogi · NCT07093580Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05233605The Role of Obesity in Severe COVID-19 Pathophysiology
NA · 1 location(s) · Franciscus Gasthuis · NCT06968442A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Phase 3 · 148 location(s) · Pfizer · NCT07013474A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Ge
Phase N/A · 1 location(s) · Pfizer · NCT05890612Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotyp
Phase 3 · 26 location(s) · Nantes University Hospital · NCT06269900Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases a
Phase N/A · 10 location(s) · Pneumonia Research Network on Genetic Resistance and Suscept · NCT05688774Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients
Phase 2 · 1 location(s) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infe · NCT07197164Imaging Immune Activation in COVID-19
Phase 2 · 1 location(s) · CellSight Technologies, Inc. · NCT04815096Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients
Phase N/A · 1 location(s) · Asan Medical Center · NCT01068990KIDney Injury in Times of COVID-19 (KIDCOV)
Phase N/A · 3 location(s) · University of California, San Francisco · NCT04705766Influence of Nutritional Indices on the Prognosis of Patients With SARS-CoV-2 Infection
Phase N/A · 1 location(s) · Juan Kang · NCT05835102The Application of Different Sedation Protocols in ICU Patients With Severe Pneumonia
Phase N/A · 1 location(s) · Xiangya Hospital of Central South University · NCT06514781Early Severe Illness TrAnslational BioLogy InformaticS in Humans
Phase N/A · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT05591924Fosfomycin I.v. for Treatment of Severely Infected Patients
Phase N/A · 50 location(s) · Infectopharm Arzneimittel GmbH · NCT02979951Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
NA · 1 location(s) · Instituto de Assistencia Medica ao Servidor Publico Estadual · NCT05354778A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Phase 2 · 12 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300320Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
Phase 2 · 2 location(s) · Hope Biosciences LLC · NCT05951777EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Ye
Phase 3 · 73 location(s) · Pfizer · NCT05261139Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and C
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04582903A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bact
NA · 1 location(s) · Henan University of Traditional Chinese Medicine · NCT07206745A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not H
Phase 3 · 248 location(s) · Pfizer · NCT06679140Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Phase 3 · 154 location(s) · Biotest · NCT05722938A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterin
Phase 1 · 1 location(s) · Ruijin Hospital · NCT06693362Presynaptic Imaging in Major Depressive Episodes After COVID-19
Phase N/A · 1 location(s) · Centre for Addiction and Mental Health · NCT06086366Defibrotide for the Treatment of Severe COVID-19
Phase 2 · 1 location(s) · Brigham and Women's Hospital · NCT04652115Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
Phase N/A · 1 location(s) · University of Ulm · NCT03044223Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
Phase 2 · 70 location(s) · BioAegis Therapeutics Inc. · NCT05947955
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.